| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 06/27/2013 | WO2013093095A1 Bisarylsulfonamides useful in the treatment of inflammation and cancer |
| 06/27/2013 | WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
| 06/27/2013 | WO2013092939A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
| 06/27/2013 | WO2013039985A3 Serine protease inhibitors |
| 06/27/2013 | CA2857257A1 Benzyl sulfonamide derivatives as rorc modulators |
| 06/26/2013 | CN103180299A Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 06/26/2013 | CN103173261A Hydroxyl imidazole functionalized ionic liquid lubricant and preparation method thereof |
| 06/26/2013 | CN103172548A Preparation method and application of methanesulfonamide compound |
| 06/26/2013 | CN103172547A Preparation and application of sulfamide derivative |
| 06/26/2013 | CN103172540A Phenylglycine histone deacetylase inhibitor as well as preparation method and applications thereof |
| 06/26/2013 | CN103172523A Method for realizing selective N-methylation of primary amine |
| 06/26/2013 | CN101973915B Intermediate of synthetic imipenem medicine as well as preparation method and application thereof |
| 06/25/2013 | US8470831 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 06/25/2013 | CA2562082C Cetp inhibitors for the treatment and prevention of atherosclerosis |
| 06/20/2013 | WO2013087498A1 Fluoroallylsulfonyl azide monomers and polymers there from |
| 06/20/2013 | WO2013086980A1 Sulfonylurea guanidine, preparation method and use thereof |
| 06/20/2013 | WO2013052943A3 Small molecule inhibitors of mcl-1 and uses thereof |
| 06/20/2013 | US20130158261 Protease inhibitors |
| 06/20/2013 | US20130158063 Compounds, Compositions and Methods Related to PPAR Antagonists |
| 06/20/2013 | CA2856176A1 Fluoroallylsulfonyl azide monomers and polymers there from |
| 06/19/2013 | EP2603487A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 06/19/2013 | EP2603481A2 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 06/19/2013 | CN103160257A Fluorocarbon surfactant, and preparation method and application thereof |
| 06/19/2013 | CN103159701A Method for synthesizing functionalized ionic liquid containing ester groups |
| 06/19/2013 | CN103159674A 2-benzene alkyl amid compound and preparation method, medical composition and use thereof |
| 06/19/2013 | CN103159651A Sulfonylurea guanidine and preparation method and application thereof |
| 06/19/2013 | CN103159650A Preparation and application of aromatic heterocyclic sulfonamide compound |
| 06/19/2013 | CN103159649A Preparation of sulfonamides compounds and application of sulfonamides compounds |
| 06/19/2013 | CN103159648A Bensulfuron-methyl universal hapten, artificial antigen, preparation method and application thereof |
| 06/19/2013 | CN101747242B Method for preparing bi-(sulfonyl fluoride) imine and (fluorinated alkyl sulfonyl fluorine sulfonyl) imine alkali metal salt |
| 06/19/2013 | CN101595088B Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 06/18/2013 | US8466316 Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof |
| 06/18/2013 | US8466201 Potassium ion channel modulators and uses thereof |
| 06/13/2013 | WO2013052279A3 Biological buffers with wide buffering ranges |
| 06/13/2013 | US20130150333 Modulators of retinoid-related orphan receptor gamma |
| 06/12/2013 | EP2600860A1 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat proteins |
| 06/12/2013 | CN103145593A Preparation method of 4,4'-diaminobenzenesulphonamide |
| 06/12/2013 | CN102584647B Industrial production method for toluene sulfonamide |
| 06/12/2013 | CN102180816B Preparation method of asymmetric type bi-fluoro sulfimide potassium |
| 06/12/2013 | CN102050765B Production method of methane sulfonamide |
| 06/12/2013 | CN101481325B Basic amino acid metalloproteinase inhibitor and use thereof |
| 06/12/2013 | CN101410370B Selective hydroxamate based MMP inhibitors |
| 06/11/2013 | US8461209 Malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 06/11/2013 | CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/06/2013 | WO2013055913A3 Pgam1 inhibitors and methods related thereto |
| 06/05/2013 | EP2598480A1 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 06/05/2013 | EP2598478A2 Arylsulfonamide derivatives, compositions, and methods of use |
| 06/05/2013 | CN103130691A Chromium fog inhibitor and preparation method thereof |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/04/2013 | US8455652 Inhibitors for the soluble epoxide hydrolase |
| 06/04/2013 | US8455497 Inhibitors of aspartyl protease |
| 05/29/2013 | EP2597083A2 Selective hydroxamate based MMP inhibitors |
| 05/29/2013 | EP2596785A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 05/22/2013 | EP2594554A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 05/22/2013 | EP2593428A2 N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels |
| 05/22/2013 | EP2593427A1 Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain |
| 05/22/2013 | CN103113242A Functional choline chloride ionic liquid and preparation method and application in electrochemical energy storage device thereof |
| 05/22/2013 | CN102153531B Intermediate for preparing dronedarone and preparation method thereof |
| 05/21/2013 | US8445722 Method for screening anti-cancer compounds inhibiting function of TM4SF5 and anti-cancer composition containing chalcone compounds |
| 05/21/2013 | US8445144 Additive for an electrolyte solution for an electrochemical device |
| 05/21/2013 | CA2401821C Amino acid derivatives as hiv aspartyl protease inhibitors |
| 05/16/2013 | WO2013068322A1 Alkenyl naphthylacetic acids for treating respiratory disorders |
| 05/16/2013 | US20130123134 Small molecule printing |
| 05/15/2013 | EP2590938A1 Novel sulfonamide compounds for inhibition of metastatic tumor growth |
| 05/15/2013 | CN103102292A Method for quickly oxidizing primary alcohol into aldehyde without pollution |
| 05/15/2013 | CN103102228A Preparation method of aryl eneyne compound |
| 05/14/2013 | CA2535714C Phenoxyacetic acid derivatives |
| 05/09/2013 | US20130116322 Alkenyl naphthylacetic acids |
| 05/09/2013 | US20130116318 Enzyme Inhibitors |
| 05/09/2013 | US20130116285 Chemical Compounds |
| 05/09/2013 | US20130116227 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 05/08/2013 | CN103087700A AM (Acrylic Amide)/NaAA (Sodium Acrylate)/AT (Diallyl Para Toluene Sulfonamide) ternary polymer oil-displacing agent and synthetic method thereof |
| 05/08/2013 | CN103086987A (1,2,3-triazolyl) sulfonyl derivative |
| 05/08/2013 | CN103086934A Photoacid generator and photoresist comprising same |
| 05/08/2013 | CN103086817A Poly-substituted phenol preparation method |
| 05/07/2013 | US8436029 Pharmaceutical forms, and methods of making and using the same |
| 05/07/2013 | US8436017 Beta-2-adrenoreceptor agonists |
| 05/02/2013 | WO2013062028A1 Hiv replication inhibitor |
| 05/02/2013 | WO2013002660A3 Process |
| 05/02/2013 | US20130109701 Chemical Compounds |
| 05/02/2013 | US20130109658 Compositions and methods for treating friedreich's ataxia |
| 05/01/2013 | EP2586435A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 05/01/2013 | CN103073460A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 05/01/2013 | CN103073372A Method for synthesizing amine compound catalyzed by functionalized ionic liquid |
| 04/25/2013 | WO2013019091A3 A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |
| 04/25/2013 | US20130102609 Biaryl oxyacetic acid compounds |
| 04/25/2013 | US20130101895 Electrolyte solution for a secondary battery |
| 04/25/2013 | DE112011101706T5 Polymerelektrolyt, Herstellungsverfahren für Polymerelektrolyt, Imidmonomer und Batterie Polymer electrolyte, manufacturing processes for polymer electrolyte imide monomer and battery |
| 04/24/2013 | CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 04/24/2013 | CN103059024A Functionalized ion liquid and application thereof |
| 04/24/2013 | CN103058897A Method for preparing chiral beta-hydroxy sulfonamide |
| 04/24/2013 | CN101815512B Cyclopropyl aryl amide derivatives and uses thereof |
| 04/24/2013 | CN101643440B Nimesulide compound and purification method thereof |
| 04/23/2013 | CA2529257C Methods and compositions for treating amyloid-related diseases |
| 04/21/2013 | CA2792724A1 Chelating compounds and immobilized tethered chelators |
| 04/18/2013 | WO2013056079A1 High affinity beta lactamase inhibitors |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096105 ArylSulfonamide Based Matrix Metalloprotease Inhibitors |
| 04/17/2013 | EP2581394A1 Ionic compound, composition, cured product, hydrogel, and ocular lens |